Next, we analyzed the accumulation of oxidative DNA lesions and the levels of DNA damage‐related proteins in Ets‐1‐overexpressing and Ets‐1‐non‐expressing breast cancer cells after treatment with different PARPi. This evidence concerns the gene ETS1 and breast carcinoma.